Black Diamond Therapeutics (BDTX) awards 40,000-share option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Black Diamond Therapeutics director Shannon Campbell received a grant of stock options covering 40,000 shares of common stock. The options have an exercise price of $1.71 per share and expire on June 25, 2036.
According to the terms, the entire option grant will vest and become exercisable on the earlier of June 26, 2027 or the company’s next annual meeting of stockholders, provided Campbell continues to serve through that date. Following this grant, Campbell holds options for 40,000 underlying shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Campbell Shannon
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 40,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,000 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 40,000 shares
Exercise price: $1.71 per share
Underlying shares: 40,000 shares
+3 more
6 metrics
Option grant size
40,000 shares
Stock Option (Right to Buy) granted to director
Exercise price
$1.71 per share
Conversion or exercise price of stock option
Underlying shares
40,000 shares
Common stock underlying the option
Total options after grant
40,000 shares
Total shares following transaction, held directly
Expiration date
June 25, 2036
Option term end date
Vesting date trigger
June 26, 2027
Earlier of this date or next annual meeting, subject to service
Key Terms
Stock Option (Right to Buy), exercise price, vesting, annual meeting of stockholders
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.7100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to this option shall vest and become exercisable in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service"
FAQ
What did Black Diamond Therapeutics (BDTX) director Shannon Campbell report on this Form 4?
Shannon Campbell reported receiving a grant of stock options for 40,000 shares of Black Diamond Therapeutics common stock. The options are a compensation-related award, not an open-market purchase, and were reported as an acquisition of derivative securities on the Form 4.
What is the exercise price of Shannon Campbell’s new Black Diamond (BDTX) stock options?
The granted stock options have an exercise price of $1.71 per share. This means Campbell can, once vested, buy Black Diamond Therapeutics common stock at $1.71 per share regardless of the future market price, until the options expire.
When do Shannon Campbell’s Black Diamond Therapeutics (BDTX) options vest?
The options vest and become exercisable in full on the earlier of June 26, 2027, or Black Diamond Therapeutics’ next annual meeting of stockholders. Vesting is conditioned on Campbell’s continued service with the company through the applicable vesting date.
When do the newly granted Black Diamond (BDTX) stock options expire?
The options are scheduled to expire on June 25, 2036. After this expiration date, Campbell would no longer be able to exercise the options to purchase Black Diamond Therapeutics common stock at the $1.71 exercise price.